Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study.
about
Safety And Efficacy Of Uninterrupted Periprocedural Apixaban In Patients Undergoing Atrial Fibrillation Catheter Ablation: A Metaanalysis Of 1,057 PatientsA Patient With Asymptomatic Cerebral Lesions During AF Ablation: How Much Should We Worry?Impact of periprocedural anticoagulation strategy on the incidence of new-onset silent cerebral events after radiofrequency catheter ablation of atrial fibrillation.Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablationTransesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban.Apixaban for periprocedural anticoagulation during catheter ablation of atrial fibrillation: a systematic review and meta-analysis of 1691 patients.Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation.New oral anticoagulants compared to warfarin for perioperative anticoagulation in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of continuous or interrupted new oral anticoagulants during ablation compared to interruptedEfficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-AnalysisEfficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.Meta-Analysis of Efficacy and Safety of Apixaban in Patients Undergoing Catheter Ablation for Atrial Fibrillation.Why develop antidotes and reversal agents for non-vitamin K oral anticoagulants?Management of Periprocedural and Early Pericardial Effusions With Tamponade Following Ablation of Atrial Fibrillation With Uninterrupted Factor Xa Inhibitors: A Case Series.Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.Are Some Anticoagulants More Equal Than Others? - Evaluating the Role of Novel Oral Anticoagulants in AF Ablation.Thromboembolic and bleeding risks in patients undergoing atrial fibrillation ablation: oral anticoagulation perspectives.Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.Use of the CHA2DS2VASc score to reduce utilisation of transoesophageal echocardiography prior to ablation for atrial fibrillation2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.Heparin Kinetics: The "Holy Grail" of Periprocedural Anticoagulation for Ablation of Atrial Fibrillation.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.Femoral venous hemostasis after atrial fibrillation ablation: Is figure-of-eight suture the way to go?Non-valvular atrial fibrillation: impact of apixaban on patient outcomes.New migraine with visual disturbance after cryoballoon ablation of atrial fibrillation.Highlights from the Ninth International Symposium of Thrombosis and Anticoagulation (ISTA IX), October 15, 2016, Salvador, Bahia, Brazil.Evaluation of left atrial thrombus prior to catheter ablation of atrial fibrillation: Is it time for an individualized approach?Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study.Complications of Atrial Fibrillation Cryoablation.Reversal Agents in the Era of NOACs.Factors impacting complication rates for catheter ablation of atrial fibrillation from 2003 to 2015.2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
P2860
Q28067702-911C9ADD-D958-4AC7-BA67-AC39F269A58DQ28077388-476A880F-4889-4EA4-A4AC-D7D803ED2F47Q30315374-7E628900-6646-4367-83FC-E7439ACF64F6Q31157420-7952F7D1-379E-4DD8-90BE-3B5C817980CBQ32177661-695D38F2-94F7-4AE3-8A2B-C71322B7A57BQ36027550-B1A1B498-1124-4A88-A5D6-3782416D6EB0Q36172403-2BD89451-2154-454D-9B7A-6F3BB921C13EQ36247011-0F7C9A6B-143E-4BEB-9D44-75176CE03716Q36999959-556AB6B0-AF8D-4B80-BA07-1D4C0BDBA4D1Q37623666-0EE1C032-5E1D-403A-B46F-3420FE548C74Q38614828-6202D229-60C1-4F0C-B6F3-6E6ED47F3B8CQ38615648-2055C2BF-98C2-47DB-A9D8-87BDC4492C50Q38693172-D7DE8467-868C-4D91-89CF-70C82EC9C4E3Q38723866-B795D94C-3A16-46E1-B7CC-8E9B690780EFQ38826010-8EC072F8-ACDF-465B-98FC-DA700CD281D2Q39285809-BB07A694-B0E0-442A-8104-E5FFB2BE00EFQ39584450-70590263-D2B1-4690-BA7D-26C95EB3796EQ39900127-2F593891-B409-4BC3-ACEA-162B467FC103Q42172443-56569319-CF2B-4A3C-983B-D97FEB5420BCQ42269593-5E4D58F0-8A9E-476E-B048-33DF7838BA8BQ42373398-B6EDE5F7-D5B9-4B68-9D41-22653866816FQ45059153-DE3BE322-7EB4-480C-B60D-D105241C4988Q45069696-381E8E64-1BB7-4B6E-9EA3-CBE41734DE49Q46600826-47D2A9CE-E89C-4F46-9E9C-BB9151139B88Q46658026-B67A0BE5-8DE8-47C5-84D1-1E00DFCE45CDQ47097907-67C4D68D-84AC-4B87-BCF9-AFDAD7605B4DQ47135998-8371AA0A-3E0A-4B7F-8829-458D465E5BC1Q47155325-409818BA-7805-4142-B386-EE8A285B1789Q47268269-D5D620E6-A6F8-4DEB-8547-19BBAAB2693FQ48344720-FB584074-09D0-4AA6-9B16-20DF6790E2C8Q48883477-12BFFC92-E4AA-46B5-BE14-CE30599935B6Q50297967-2A5A6A41-6935-4F1F-8131-867288655A5FQ50333195-8221324D-6441-4173-B00C-51AE03B73BFFQ50906422-BBB958F7-26D3-4DC4-BB04-5BBD374AE4EFQ55263071-55E69209-4024-4453-A8BD-C2484405C100
P2860
Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Feasibility and safety of unin ...... ults from a multicenter study.
@ast
Feasibility and safety of unin ...... ults from a multicenter study.
@en
type
label
Feasibility and safety of unin ...... ults from a multicenter study.
@ast
Feasibility and safety of unin ...... ults from a multicenter study.
@en
prefLabel
Feasibility and safety of unin ...... ults from a multicenter study.
@ast
Feasibility and safety of unin ...... ults from a multicenter study.
@en
P2093
P921
P1433
P1476
Feasibility and safety of unin ...... ults from a multicenter study.
@en
P2093
Amin Al-Ahmad
Andrea Natale
Anja Schade
Atilla Szoelloes
Carola Gianni
Chintan Trivedi
Dhanujaya Lakkireddy
Elisabeth Sigmund
G Joseph Gallinghouse
Helmut Pürerfellner
P304
P356
10.1016/J.HRTHM.2015.02.028
P577
2015-02-26T00:00:00Z